Interferon α-2b treatment in a murine model for metastatic ocular melanoma.

被引：0
|
作者：
Dithmar, S
Rusciano, D
Lawson, DH
Grossniklaus, HE
机构：
[1] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
[3] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
[4] Univ Heidelberg, Dept Ophthalmol, D-6900 Heidelberg, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2000年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
568
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [31] Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma
    Hwu, Wen-Jen
    PanageaS, Katherine S.
    Menell, Jennifer H.
    Lamb, Lynne A.
    Aird, Suzan
    Krown, Susan E.
    Williams, Linda J.
    Chapman, Paul B.
    Livingston, Philip O.
    Wolchok, Jedd D.
    Houghton, Alan N.
    CANCER, 2006, 106 (11) : 2445 - 2451
  • [32] Adjuvant pegylated interferon α-2b therapy for melanoma
    Schilling, Bastian
    Vaubel, Julia
    Schadendorf, Dirk
    ONCOLOGY LETTERS, 2010, 1 (02) : 237 - 241
  • [33] TREATMENT PATTERNS OF ADJUVANT INTERFERON ALFA-2B (IFN-α2B) FOR HIGH-RISK MELANOMA. A RETROSPECTIVE STUDY OF THE GRUPO ESPAnOL MULTIDISCIPLINAR DE MELANOMA (GEM)
    Martin-Algarra, S.
    Soriano, V.
    Malvehy, J.
    Berrocal, A.
    Quindos, M.
    Martinez Del Prado, P.
    Soria, A.
    Marquez-Rodas, I.
    Palacio, I.
    Cerezuela, P.
    Alonso, L.
    Lopez-Vivanco, G.
    Nocea, G.
    Stevinson, K.
    Del Barrio, P.
    Tornamira, M. V.
    Guillem Porta, V.
    Espinosa, E.
    ANNALS OF ONCOLOGY, 2014, 25
  • [34] Adjuvant topical interferon-α-2b treatment in epithelial tumors of the ocular surface
    Fuchsluger, TA
    Hintschich, C
    Steuhl, KP
    Meller, D
    OPHTHALMOLOGE, 2006, 103 (02): : 124 - 128
  • [35] Efficacy of immunotherapy and sequencing of checkpoint inhibition for metastatic ocular melanoma.
    Abhyankar, Anuja
    Maharaj, Satish
    Miller, Donald M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] A pilot study of low-dose thalidomide and interferon α-2b in patients with metastatic melanoma who failed prior treatment
    Solti, Magdoina
    Berd, David
    Mastrangelo, Michael J.
    Sato, Takami
    MELANOMA RESEARCH, 2007, 17 (04) : 225 - 231
  • [37] Ocular surface toxicity associated with topical interferon α-2b
    Aldave, Anthony J.
    Nguyen, Anne
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (08) : 1087 - 1088
  • [38] High dose interferon-α-2b adjuvant treatment for melanoma:: The UK experience
    Katerinaki, E
    Kularatne, B
    Hambly, R
    Turner, L
    Hancock, BW
    Lorigan, P
    BRITISH JOURNAL OF CANCER, 2003, 88 : S66 - S66
  • [39] Autoimmune thyroiditis after treatment with interferon alpha-2a/2b in malignant melanoma
    Zaplatnikov, K
    Spieth, K
    Menzel, C
    Hamscho, N
    Döbert, N
    Diehl, M
    Hoffmann, M
    Diener, J
    Kaufmann, R
    Grünwald, F
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
  • [40] Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon α2b in patients with metastatic melanoma
    Bar, Jair
    Yerushalmi, Rinat
    Shapira-Frummer, Roni
    Kutchuk, Irena
    Sulkes, Aaron
    Gutman, Haim
    Catane, Raphael
    Schachter, Jacob
    ONCOLOGY REPORTS, 2008, 20 (06) : 1533 - 1538
12345